Global Lung Cancer Surgery Market Size To Reach USD 7


Selbyville, Delaware, July 13, 2021 (GLOBE NEWSWIRE) – According to the informed opinions of expert analysts and seasoned forecasters, lung cancer surgery market, valued at $ 5.4 billion in 2020, is expected to register a CAGR of 3.8% over 2021-2027 and thereafter amass a valuation of $ 7 billion by the end of the stipulated period.

Taking the analysis further, a detailed country-level survey of key regions, namely Asia-Pacific, Europe, North America and Latin America is presented in the research paper. Moreover, the market is also studied from the perspective of surgical devices and surgical procedures. The research article also presents a 360-degree perspective of the competitive arena with respect to leading companies, emerging competitors and new players in this field.

The increasing prevalence of lung cancer across the world is increasing the growth of the industry. In fact, the World Health Organization claims that cancer was the second leading cause of death in the world in 2018. In addition, more than 10 million cancer deaths and 19.3 million new cases were recorded in 2020.

Request a copy of this report @

The high risk factor among the growing number of tobacco smokers and the burgeoning elderly population are also driving the growth of the industry. In addition, the technological advancements in cancer treatment, the increasing trend of early detection and treatment of cancer, as well as the positive outlook for the reimbursement scenario add considerable impetus to the expansion of the industry.

On the contrary, the high costs associated with diagnostics and surgeries will negatively impact the growth of the industry in the years to come.

Overview of the geographic analysis:

Asia-Pacific, North America, Latin America and Europe are the major contributors to the overall expansion of the lung cancer surgery market. Among these regions, North America currently holds the majority share of the industry and is likely to record significant gains in the years to come. This can be attributed to the increase in technological innovations and the increasing frequency of lung cancer in the region.

The Asia-Pacific market is expected to exhibit a remarkable growth rate during the assessment period due to the increasing consumption of tobacco and the increased emphasis on early diagnosis and treatment of cancer.

Review of the competitive landscape:

Accuray Inc., AngioDynamics Inc., Ethicon US LLC, Intuitive Surgical Inc., Olympus Corp., Teleflex Inc., Ackermann Instrumente GmbH, Richard Wolf GmbH, Siemens Healthineers AG and Scanlan International Inc. are the leading candidates influencing lung cancer in the dynamic world of the surgery industry. These players are increasingly focusing on research and development, partnerships and investments to improve their market position.

To access a sample copy or view this report in detail and the table of contents, please click on the link below:

Global Lung Cancer Surgery Market, by Surgical Devices (Revenue, USD Billion, 2018-2027)

  • Monitoring and visualization systems
  • Surgical instruments
  • Endosurgical equipment

Global Lung Cancer Surgery Market, by Surgical Procedures (Revenue, USD Billion, 2018-2027)

  • Minimally invasive surgeries
  • Thoracotomy

Geographic Bifurcation of Global Lung Cancer Surgery Market (Revenue, USD Billion, 2018-2027)

North America


  • Germany
  • France
  • UK
  • Italy
  • Spain
  • The rest of europe

Asia Pacific

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • Rest of the APAC

Latin America

Rest of the world

Competitive Dashboard of Global Lung Cancer Surgery Market (Revenue, USD Billion, 2018-2027)

  • Richard Wolf GmbH
  • Siemens Healthineers SA
  • Scanlan International Inc.
  • Ackermann Instrumente GmbH
  • Teleflex inc.
  • Olympus Corp.
  • Intuitive Surgical Inc.
  • Ethicon US LLC
  • AngioDynamics Inc.
  • Accuray Inc.


Chapter 1. Executive summary

1.1. Market Snapshot

1.2. Global and Segmental Market Estimates and Forecasts, 2019-2027 (USD Billion)

1.2.1. Lung Cancer Surgery Market, by Region, 2019-2027 (USD Billion)

1.2.2. Lung Cancer Surgery Market, by Surgical Devices, 2019-2027 (USD Billion)

1.2.3. Lung Cancer Surgery Market, by Surgical Procedure, 2019-2027 (USD Billion)

1.3. Key trends

1.4. Estimation methodology

1.5. Research hypothesis

Chapter 2. Definition and Scope of Global Lung Cancer Surgery Market

2.1. Goal of the study

2.2. Definition and scope of the market

2.2.1. Scope of the study

2.2.2. Evolution of the industry

2.3. Years taken into account for the study

2.4. Currency conversion rates

Chapter 3. Global Lung Cancer Surgery Market Dynamics

3.1. Lung Cancer Surgery Market Impact Analysis (2019-2027)

3.1.1. Market factors Increased incidence of lung cancer The growing tendency to smoke tobacco

3.1.2. Market restriction high cost of diagnosing and treating lung cancer

3.1.3. Market opportunities Emerging economies

Chapter 4. Global Lung Cancer Surgery Market Industry Analysis

4.1. Model 5 Force de Porter

4.1.1. Bargaining power of suppliers

4.1.2. The bargaining power of buyers

4.1.3. The threat of new participants

4.1.4. The threat of substitutes

4.1.5. Competitive rivalry

4.1.6. Futuristic approach to Porter’s 5 forces model (2018-2027)

4.2. PEST analysis

4.2.1. Politics

4.2.2. Economic

4.2.3. Social

4.2.4. Technological

4.3. Investment adoption model

4.4. Analyst recommendation and conclusion

Chapter 5. Global Lung Cancer Surgery Market, By Surgical Devices

5.1. Market Snapshot

5.2. Global Lung Cancer Surgery Market by Surgical Devices, Performance – Potential Analysis

5.3. Global Lung Cancer Surgery by Surgical Device Market Estimates & Forecasts 2018-2027 (USD Billion)

5.4. Lung Cancer Surgery Market, Sub-Segment Analysis

5.4.1. Surgical instruments

5.4.2. Monitoring and visualization systems

5.4.3. Endosurgical equipment

Chapter 6. Global Lung Cancer Surgery Market, By Surgical Procedures

6.1. Market Snapshot

6.2. Global Lung Cancer Surgery Market by Surgical Procedures, Performance – Potential Analysis

6.3. Global Lung Cancer Surgery by Surgical Procedure Market Estimates & Forecasts 2018-2027 (USD Billion)

6.4. Lung Cancer Surgery Market, Sub-Segment Analysis

6.4.1. Thoracotomy

6.4.2. Minimally invasive surgeries

Chapter 7. Global Lung Cancer Surgery Market, Regional Analysis

Related report:

Global Surgical Robots Market Size Study and Regional Forecast 2021-2027

Global Surgical Robots Market to reach USD 16.92 billion by 2027. The global surgical robots market is valued at approximately USD 5.44 billion in 2020 and is expected to grow with a healthy growth rate of over 17.6% during the period forecast 2021-2027. Robotic surgery is a type of minimally invasive surgery in which doctors use very small surgical instruments that fit into the patient’s body through a series of tiny incisions. Additionally, used for a number of different procedures including coronary artery bypass grafting, removing cancerous tissue from sensitive parts of the body such as blood vessels, nerves or important organs in the body, removing the gall bladder, etc. Demand for minimally invasive surgeries, more and more technologies, highly advanced visualization capabilities, increasing investments in advanced healthcare infrastructure have led to the adoption of the surgical robots market during the forecast period.

Cancer Diagnostics Market Size, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share and Forecast, 2020-2026

The Global cancer diagnostics market The share has grown substantially over the past decade or so due to the increasing prevalence of cancer worldwide. Unhealthy eating habits, sedentary lifestyles, including smoking and excessive alcohol consumption, and increasing obesity are mainly responsible for the increase in the number of cancer cases. According to the American Cancer Society, there are 1.8 million new cancer cases diagnosed in 2020 and 606,520 cancer deaths in the United States alone. Latin America is expected to become a lucrative growth ground for the cancer diagnostics market, thanks to the high prevalence of cancer in the region. The Latin America market is expected to exceed $ 7.3 billion by 2026, with regional governments providing sufficient funding for research activities to detect new diagnostic techniques. In addition, the region’s health care infrastructure has been developed to a large extent, making it a viable avenue for cancer diagnostic activities.

The Middle East and Africa region is also becoming a critical revenue pocket for the cancer diagnostics industry. Estimates claim that the size of the MEA market was worth $ 856.9 million in 2019 and could represent substantial growth in the years to come.

About Us:

Market Research Report, LLC. is a hub for market intelligence products and services.

We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services together in one place.

Our clients partner with Market Study Report, LLC. to facilitate their research and evaluation of market intelligence products and services and in turn focus on the core activities of their business.

If you are looking for research reports on global or regional markets, information on the competition, emerging markets and trends, or if you are just looking to stay on top, then Market Study Report, LLC. is the platform that can help you achieve any of these goals.


Comments are closed.